Journal of Immunology : Impact Factor & More
eISSN: 1550-6606pISSN: 0022-1767
Share this on:
Key Metrics
CiteScore 
8.9
Impact Factor
< 5
Scite Index
0.92 5-Year SI
SNIP
1.15
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Journal of Immunology Journal Specifications
Indexed in the following public directories
Web of Science 
SJR
| Overview | |
| Publisher | AMER ASSOC IMMUNOLOGISTS |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 1916 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Immunology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Journal of Immunology
Clinical use and adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: The role of comorbidities.
- 1 Jul 2026
- Leukemia research
Comparison of adverse event profiles of carfilzomib-, elotuzumab-, and ixazomib-based therapies combined with lenalidomide and dexamethasone in patients with multiple myeloma using VigiBase.
- 1 Jul 2026
- Leukemia research
Risk factors and fluid management in tumor lysis syndrome of acute myeloid leukemia: A retrospective study.
- 1 Jul 2026
- Leukemia research
Systemic evaluation for extramedullary disease and treatment outcomes in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
- 1 Jun 2026
- Leukemia research
Efficacy of hypomethylating agents in combination with venetoclax in relapsed/refractory acute myeloid leukemia: A systematic review and meta-analysis.
- 1 Jun 2026
- Leukemia research
Retrospective, single-center analysis of second allogeneic stem cell transplantation versus non-transplant regimens for acute myeloid leukemia patients with relapse after first transplantation.
- 1 Jun 2026
- Leukemia research
Clinical use and adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: The role of comorbidities.
- 1 Jul 2026
- Leukemia research
Comparison of adverse event profiles of carfilzomib-, elotuzumab-, and ixazomib-based therapies combined with lenalidomide and dexamethasone in patients with multiple myeloma using VigiBase.
- 1 Jul 2026
- Leukemia research
Risk factors and fluid management in tumor lysis syndrome of acute myeloid leukemia: A retrospective study.
- 1 Jul 2026
- Leukemia research
Systemic evaluation for extramedullary disease and treatment outcomes in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
- 1 Jun 2026
- Leukemia research
Efficacy of hypomethylating agents in combination with venetoclax in relapsed/refractory acute myeloid leukemia: A systematic review and meta-analysis.
- 1 Jun 2026
- Leukemia research
Retrospective, single-center analysis of second allogeneic stem cell transplantation versus non-transplant regimens for acute myeloid leukemia patients with relapse after first transplantation.
- 1 Jun 2026
- Leukemia research
FAQs on Journal of Immunology
How long has Journal of Immunology been actively publishing? 
What is the publishing frequency of Journal of Immunology?
How many articles did Journal of Immunology publish last year?
What is the eISSN & pISSN for Journal of Immunology?
What is Citescore for Journal of Immunology?
What is SNIP score for Journal of Immunology?
Who is the publisher of Journal of Immunology?
